SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
jhcimmu
Olecranon
To: Olecranon who wrote (63100)5/15/2025 2:02:01 PM
From: allatwwk2 Recommendations  Read Replies (1) of 63285
 
Companies ranked high on innovation and invention at the STAT conference. The presenter was from IDEA Pharma.

Innovation can be thought of as new product revenues, invention can be thought of as novel drug portfolio and clinical trials. The presenter indicated the distinction is somewhat based on what would a company do with a phase 1 molecule. Effectively, invention is getting good molecules into trials.innovation is what companies do with those molecules.

These are the companies on the top right of the graphic, with innovation and invention as the axes:

1. AstraZeneca

Also in that area of the graphic, a bit below AZ are: Roche, J&J Regeneron, Pfizer, Merck, Lilly

Gilead was middle of the pack on both, similar spot to Sanofi, Hengrui, Daiichi Sankyo, BioNTech, Boehringer Ingelheim. I counted 30 companies on the graphic.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext